导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.52% | 426/1050 |
| 近一周 | -2.89% | 905/1104 |
| 近一月 | -5.55% | 821/1103 |
| 近一季 | -7.73% | 604/1092 |
| 近半年 | -4.36% | 600/1070 |
| 近一年 | 11.71% | 345/1018 |
| 近两年 | 51.77% | 504/926 |
| 近三年 | 22.85% | 470/834 |
| 成立以来 | 294.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.86% 148/1070 |
8.08% 570/1101 |
- - |
- - |
| 2025 | 22.50% 624/1065 |
2.59% 598/1014 |
-3.46% 909/1038 |
22.09% 533/1050 |
1.31% 363/1065 |
| 2024 | -0.98% 609/1011 |
-3.08% 479/960 |
-5.11% 641/983 |
15.64% 194/991 |
-6.89% 774/1011 |
| 2023 | 0.36% 91/952 |
8.00% 173/880 |
1.02% 133/895 |
-5.44% 342/915 |
-2.72% 296/952 |
| 2022 | -18.09% 258/867 |
-14.91% 257/773 |
3.13% 623/806 |
-7.81% 133/845 |
1.25% 369/867 |
| 2021 | 16.68% 177/740 |
0.97% 110/580 |
5.36% 461/659 |
2.92% 169/704 |
6.57% 160/740 |
| 2020 | 87.89% 67/554 |
4.20% 84/419 |
27.22% 158/466 |
15.06% 141/517 |
23.18% 90/554 |
| 2019 | 35.45% 258/410 |
21.68% 880/1146 |
-2.85% 573/1228 |
4.74% 205/390 |
9.39% 179/410 |
| 2018 | -19.83% 74/349 |
- - |
-6.74% 250/990 |
-3.58% 397/1000 |
-11.78% 525/1080 |
| 2017 | 24.53% 67/285 |
- - |
- - |
- - |
- - |
| 2016 | 17.96% 1/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 圆信永丰优加生活 VS. 东吴新产业精选股票A(580008) |